BBIO Latest Quarter’s Earnings
Announce Date10/29/2026
EPS Actual (USD)-0.42
Revenue Actual (USD)353.17M
BridgeBio Pharma Inc Earnings Dates & Reports
This page offers detailed BridgeBio Pharma Inc earnings data including the latest BridgeBio Pharma Inc earnings report, the upcoming BridgeBio Pharma Inc earnings date, historical data and BridgeBio Pharma Inc earnings call news.
BBIO Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
BBIO FY2025 Earnings
EPS (YoY)-3.79-31.46%
Revenue (YoY)502.08M126.26%
BridgeBio Pharma Inc (BBIO) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 10/29/2026 | 09/2026 | -0.42/-0.58 | 353.17M/288.05M | 26.89% | 22.61% |
| 8/10/2026 | 06/2026 | -0.78/-0.58 | 243.68M/218.74M | -33.25% | 11.40% |
| 5/7/2026 | 03/2026 | -0.84/-0.68 | 194.51M/177.94M | -24.11% | 9.32% |
| 2/24/2026 | 12/2025 | -1.00/-0.74 | 154.18M/146.84M | -34.25% | 4.99% |
| 10/29/2025 | 09/2025 | -0.95/-0.89 | 120.70M/106.39M | -7.18% | 13.45% |
| 8/5/2025 | 06/2025 | -0.95/-0.84 | 110.56M/91.41M | -13.22% | 20.96% |
| 4/29/2025 | 03/2025 | -0.88/-0.92 | 116.63M/61.94M | 4.64% | 88.30% |
| 2/20/2025 | 12/2024 | -1.40/-1.13 | 5.88M/3.48M | -23.71% | 69.05% |
BridgeBio Pharma Inc Latest Earnings Call Transcripts
BridgeBio Pharma (BBIO) Q3 2026 Earnings Call: Attruby Revenue Up 134%, Three Launches Ahead
BridgeBio Pharma’s Q3 2026 revenue reached $353.2 million as Attruby sales rose 134%, while three priority-review FDA decisions approach.